Catheter Precision Inc. (VTAK) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Catheter Precision Inc. (VTAK) has a cash flow conversion efficiency ratio of -0.227x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.51 Million) by net assets ($6.65 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Catheter Precision Inc. - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how Catheter Precision Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read VTAK total debt and obligations for a breakdown of total debt and financial obligations.
Catheter Precision Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Catheter Precision Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Tristel
LSE:TSTL
|
0.161x |
|
Gibui Holdings Ltd
TA:GIBUI
|
-0.080x |
|
The Income & Growth VCT
LSE:IGV
|
-0.017x |
|
Augmentum Fintech PLC
LSE:AUGM
|
-0.009x |
|
Crown LNG Holdings Limited Warrants
NASDAQ:CGBSW
|
-0.192x |
|
Supreme PLC
LSE:SUP
|
0.044x |
|
Ceylon Graphite Corp
V:CYL
|
1.418x |
|
Crest Nicholson Holdings plc
LSE:CRST
|
0.080x |
Annual Cash Flow Conversion Efficiency for Catheter Precision Inc. (2016–2025)
The table below shows the annual cash flow conversion efficiency of Catheter Precision Inc. from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see VTAK market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $6.65 Million | $-8.30 Million | -1.247x | -58.18% |
| 2024-12-31 | $11.76 Million | $-9.27 Million | -0.789x | +18.95% |
| 2023-12-31 | $21.19 Million | $-20.62 Million | -0.973x | +60.08% |
| 2022-12-31 | $9.26 Million | $-22.57 Million | -2.437x | -20.63% |
| 2021-12-31 | $13.67 Million | $-27.62 Million | -2.020x | -50.95% |
| 2020-12-31 | $21.15 Million | $-28.30 Million | -1.338x | -33.75% |
| 2019-12-31 | $33.15 Million | $-33.17 Million | -1.001x | -260.66% |
| 2018-12-31 | $66.70 Million | $-18.51 Million | -0.277x | -138.26% |
| 2017-12-31 | $-7.62 Million | $-5.52 Million | 0.725x | -85.39% |
| 2016-12-31 | $-380.00K | $-1.89 Million | 4.963x | -- |
About Catheter Precision Inc.
Catheter Precision, Inc. designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States and Europe. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally … Read more